Dergiler / Diagnostic and Interventional Radiology / 2016 / Cilt: 22 - Sayı: 6

Starclose SE® hemostasis after 6F direct antegrade superficial femoral artery access distal to the femoral head for peripheral endovascular procedures in obese patients

Sayfa
542–547
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Uncomplicated hemostasis was achieved even in cases of puncturing 2 to 7 cm below the inferior edge of the femoral head.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE Direct superficial femoral artery (SFA) antegrade puncture is a valid alternative to common fem-oral artery (CFA) access for peripheral vascular interventions.
📊
Temel Bulgular & Veri:Data investigating vascular closure device (VCD) hemostasis of distant SFA 6F access are limited.
💡
Sonuç & Katkı:Uncomplicated hemostasis was achieved even in cases of puncturing 2 to 7 cm below the inferior edge of the femoral head.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

PURPOSE Direct superficial femoral artery (SFA) antegrade puncture is a valid alternative to common fem-oral artery (CFA) access for peripheral vascular interventions. Data investigating vascular closure device (VCD) hemostasis of distant SFA 6F access are limited. We aimed to investigate the safety and effectiveness of the Starclose SE® VCD for hemostasis, following direct 6F antegrade SFA access distal to the femoral head.METHODSThis prospective, single-center study included patients who were not suitable for CFA puncture and were scheduled to undergo peripheral endovascular interventions using direct antegrade SFA 6F access, at least 2 cm below the inferior edge of femoral head. Hemostasis was obtained with the Starclose SE® VCD (Abbott Laboratories). Primary endpoints were successful hemostasis rate and periprocedural (30-day) major complication rate. Secondary endpoint was the rate of minor complications. Clinical and Doppler ultrasound follow-up was performed at discharge and at one month.RESULTSBetween September 2014 and August 2015, a total of 30 patients (21 male; 70.0%) with a mean body mass index of 41.2 kg/m2 were enrolled. Mean age was 72±9 years (range, 67-88 years). Most patients suffered from critical limb ischemia (87.1%) and diabetes (61.3%). Calcifications were pres-ent in eight cases (26.6%). Reason for direct SFA puncture was obesity (100%). Successful hemo-stasis was achieved in 100% of the cases. No major complications were noted after one-month fol-low-up. Minor complications included two <5 cm hematomas (6.6%) not necessitating treatment.CONCLUSIONIn this prospective study, Starclose SE® VCD was safe and effective for hemostasis of antegrade direct SFA puncture. Uncomplicated hemostasis was achieved even in cases of puncturing 2 to 7 cm below the inferior edge of the femoral head.

🔖

Bu Makaleye Atıf Yap

SPİLİOPOULOS, S., KITORU, P., CHRISTEAS, N., KARNABATIDIS, D. (2016). Starclose SE® hemostasis after 6F direct antegrade superficial femoral artery access distal to the femoral head for peripheral endovascular procedures in obese patients. Diagnostic and Interventional Radiology, Cilt: 22 - Sayı: 6, 542–547. https://ajindex.com/articles/350046

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Rooke TW, Hirsch AT, Misra S, et al. Manage- ment of patients with peripheral artery dis- ease (compilation of 2005 and 2011 ACCF/ AHA guideline recommendations): A report of the American College of Cardiology Foun- dation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2013; 61:1555-1570. [CrossRef] Norgren L, Hiatt WR, Dormandy JA, et al. TASC II Working Group. Inter-society consensus for the management of peripheral arterial dis- ease (TASCII). 2007; Eur J Vasc Endovasc Surg 33(Suppl 1):S1-S75. [CrossRef] Bangalore S, Bhatt D. Femoral arterial access and closure. Circulation 2011; 124:e147-156. [CrossRef] Altin RS, Flicker S, Naidech HJ. Pseudoaneu- rysm and arteriovenous fistula after femoral artery catheterization: association with low femoral punctures. AJR Am J Roentgenol 1989; 152:629-631. [CrossRef] Stone PA, Campbell JE. Complications related to femoral artery access for transcatheter proce- dures. Vasc Endovascular Surg 2012; 46:617-623. [CrossRef] Wager J, Gandhi RT, Powell A. Technical ap- proach to antegrade femoral access. Tech Vasc Interv Radiol 2015; 18:82-86. [CrossRef] Spiliopoulos S, Katsanos K, Diamantopou- los A, Karnabatidis D, Siablis D. Does ultra- sound-guided lidocaine injection improve local anaesthesia before femoral artery cath- eterization? Clin Radiol 2011; 66:449-455. [CrossRef] Rimon U, Khaitovich B, Yakubovich D, Bensaid P, Golan G, Silverberg D. The use of ExoSeal vas- cular closure device for direct antegrade super- ficial femoral artery puncture site hemostasis. Cardiovasc Intervent Radiol 2015; 38:560-564. [CrossRef] Schulz-Schüpke S, Helde S, Gewalt S, et al. Com- parison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA 2014; 312:1981-1987. [CrossRef] Tavris DR, Wang Y, Jacobs S, et al. Bleeding and vascular complications at the femoral access site following percutaneous coronary interven- tion (PCI): an evaluation of hemostasis strate- gies. J Invasive Cardiol 2010; 22:599-607.
  2. Spiliopoulos S, Katsanos K, Karnabatidis D, Dia- mantopoulos A, Nikolaos C, Siablis D. Safety and efficacy of the StarClose vascular closure device in more than 1000 consecutive periph- eral angioplasty procedures. J Endovasc Ther 2011; 18:435-443. [CrossRef] Williams RE, Angel CY, Bourkaib R, et al. Multi- center safety and efficacy analysis of assisted closure after antegrade arterial punctures us- ing the StarClose device. J End